BenchSci

formerly Scinapsis Analytics

Unlocking the Black Box of Disease Biology

Toronto, Canada · Founded 2015 · $265.2M raised

Headquarters
Toronto
Employees
201–500
Founded
2015
Business Model
SaaS
Total Funding
$265.2M
Last Round
$70.0M Series DMay 2023
Rounds
8

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

BenchSci is a world leader in AI solutions for preclinical R&D, using proprietary neurosymbolic AI to decode disease biology. The platform integrates a Biological Evidence Knowledge Graph with foundation models to provide AI copilots that accelerate hypothesis testing and drug discovery from years to days. It combines public, licensed, and internal data for biopharma teams.

Summary

BenchSci is an Artificial Intelligence company based in Toronto, Canada, founded in 2015. It has raised $265.2M in total across 8 rounds, most recently a $70.0M Series D round in May 2023. Investors include Inovia Capital, Generation Investment Management and TCV.

Tech & App Stack

16 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DMay 2023
$70.0M

Sign up to see all 8 events

Funding: Seed through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Lila Sciences

Lila Sciences combines artificial intelligence with autonomous laboratories to accelerate scienti...

Cambridge, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.3BJun 2026
Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech, Healthcare
Series ETotal funding$1.2BJun 2025
Commure

Commure provides AI-powered healthcare software that automates revenue-cycle, clinical documentat...

Mountain View, United States501–1000Artificial Intelligence, Healthcare
Series FTotal funding$1.2BMay 2026
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BenchSci on Indexed.vc
<a href="https://indexed.vc/companies/benchsci"><img src="https://indexed.vc/api/badge/company/benchsci" alt="BenchSci on Indexed.vc" width="260" height="76" /></a>